Biogen (BIIB)
(Delayed Data from NSDQ)
$230.04 USD
-5.28 (-2.24%)
Updated May 16, 2024 04:00 PM ET
After-Market: $229.99 -0.05 (-0.02%) 4:38 PM ET
3-Hold of 5 3
C Value B Growth B Momentum B VGM
Brokerage Reports
0 items in cart
Biogen Inc. [BIIB]
Reports for Purchase
Showing records 701 - 720 ( 799 total )
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Part 3 of Our Alzheimers Series: Biogens Approach to Tau and Neuroinflammation
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Informing Therapeutic Strategies and Predicting Rates of Decline in Alzheimers Disease
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Our Focus Is on Alzheimers; Initiating with a Buy Rating and $380 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ending Jan 9
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ending Jan 2
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker- Week Ended Dec 12
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Dec 5
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology/Biopharmaceuticals/BioDefense-Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Nov 14
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D